RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > China-Focused USP Committee to Develop Excipient Standards

China-Focused USP Committee to Develop Excipient Standards

Posted 29 November 2011 | By

The US Pharmacopeia (USP) is creating a China-focused East Asia expert committee to develop quality standards for excipients.  In June, the USP released details regarding its plans to create a free, online collection of voluntary public standards, called the Medicines Compendium (MC).  Development of these first ten standards was shaped by comments from USP staff and the MC South Asia expert committee.  USP chose to create its first MC-focused body in South Asia due to India's central role in exporting medicines.  The next committee is forming in East Asia and will be composed of Chinese scientists.  Initially, the committee will focus on developing quality standards for excipients. (In-Pharma Technologist)


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.